Comparison
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786 vs 2 5 Toe Syndactyly C4023724
Clinical comparison between 3 Methylcrotonyl Coa Carboxylase 1 Deficiency CN028786 and 2 5 Toe Syndactyly for differential diagnosis and treatment planning.
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
A metabolic disorder affecting the processing of leucine, an amino acid. Symptoms may include developmental delay, low blood sugar, and feeding problems. Dietary restrictions and supplementation are typically used in management.
2 5 Toe Syndactyly C4023724
A birth condition where the second and fifth toes are webbed together. This mild toe abnormality may not affect function and can be treated with surgery if preferred.
6 comparison axes
Onset
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
0-null
2 5 Toe Syndactyly C4023724
0-0
Onset patterns differ
Severity
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
severe
2 5 Toe Syndactyly C4023724
mild
Different severity levels
Chronic
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
Chronic
2 5 Toe Syndactyly C4023724
Chronic
Differing course
Communicable
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
No
2 5 Toe Syndactyly C4023724
No
Different transmission
Body System
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
metabolic
2 5 Toe Syndactyly C4023724
musculoskeletal
Same/different system
Category
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
metabolic
2 5 Toe Syndactyly C4023724
other
Different category
Bottom line
3-methylcrotonyl-coa-carboxylase-1-deficiency-CN028786 and 2-5-toe-syndactyly-C4023724 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786 | 2 5 Toe Syndactyly C4023724 | Discriminating power |
|---|---|---|---|
| Systemic metabolic features | May include feeding problems, low blood sugar, or developmental delay; none is universal. | Isolated toe webbing is not expected to cause metabolic symptoms. | High |
| Toe appearance | No characteristic fusion of the second and fifth toes is described. | The second and fifth toes are webbed from birth. | High |
| Functional severity | Described as potentially severe and chronic when metabolic complications occur. | Usually mild and may not impair walking or function. | Moderate |
When to favor each condition
Choose 3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786 when
Leucine-related metabolites are reported
This points toward a metabolic disorder rather than a structural toe finding.
Moderate
Poor feeding, lethargy, or documented hypoglycemia
These features fit the supplied metabolic description, not syndactyly.
Moderate
Developmental concerns suggest a metabolic cause
Further clinician-directed evaluation is appropriate; syndactyly does not explain them.
Low
Choose 2 5 Toe Syndactyly C4023724 when
Second-to-fifth toe webbing is visible at birth
This directly matches the congenital musculoskeletal description.
High
Metabolic testing is unremarkable and findings are isolated
An isolated structural finding is more consistent than metabolic disease.
Moderate
Advice concerns appearance or optional surgery
Function may be preserved, so treatment preference requires individual assessment.
Moderate
How key tests differ
| Test | 3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786 | 2 5 Toe Syndactyly C4023724 | Interpretation |
|---|---|---|---|
| Acylcarnitine or urine organic acid testing | May show leucine-pathway abnormalities; no cutoff is established here. | No metabolic abnormality is expected when syndactyly is isolated. | Abnormal metabolites support metabolic evaluation but do not alone confirm the diagnosis. |
| Blood glucose during illness | Low blood sugar may occur but is not specific or definitive. | Toe webbing alone is not expected to alter glucose. | Hypoglycemia needs urgent clinical assessment and broader diagnostic consideration. |
| Foot examination or radiograph | No characteristic toe-fusion finding is described. | Soft-tissue webbing is visible; bone involvement varies and must be assessed. | Imaging clarifies anatomy but provides no information about leucine metabolism. |
Prognosis comparison
3 Methylcrotonyl Coa Carboxylase 1 Deficiency Cn028786
- Outcome
- Variable and potentially severe, but individual outcome is not established from these data.
- Factors
- Metabolic stability, illness episodes, development, and specialist follow-up.
2 5 Toe Syndactyly C4023724
- Outcome
- Generally mild, with function often preserved.
- Factors
- Extent of webbing, bone involvement, function, and surgical preference.
Time frame: Both may be recognized in early life; exact timelines are not established.
Severity, associated findings, anatomy, and access to appropriate care.
Complications comparison
| Complication | Presentation |
|---|---|
| Metabolic decompensation | Feeding difficulty, hypoglycemia, or neurologic effects may occur; frequency is not established. Not a described complication of isolated toe syndactyly. Urgent care should address metabolic symptoms rather than toe appearance. |
| Developmental concerns | Developmental delay may be part of the condition. Not expected from mild isolated syndactyly. Delay requires broader evaluation; a causal link should not be assumed. |
| Foot function or appearance | Not described as a primary feature. Usually mild; surgery may be considered for preference or uncommon functional limitation. Decisions depend on anatomy, function, and patient or family preference. |
Patient education highlights
- HighDistinct conditions
These are not alternative names for one disease and affect different body systems.
- HighMetabolic warning symptoms
Poor feeding, unusual sleepiness, or low blood sugar need prompt clinical advice; do not change diet independently.
- MediumToe treatment choices
Syndactyly may not limit function. Surgery is individualized and often elective.